These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16275003)

  • 1. Old skills in a new context. But do we want to use it?
    Vaage J
    Eur J Cardiothorac Surg; 2005 Dec; 28(6):831-2. PubMed ID: 16275003
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrillatory arrest technique: is it worth tasting the old wine in new bottle?
    Mishra PK
    Eur J Cardiothorac Surg; 2006 May; 29(5):860; author reply 861. PubMed ID: 16520049
    [No Abstract]   [Full Text] [Related]  

  • 3. The potential of pre and post conditioning to prevent cardiac ischemic sequelae.
    Meijer RC; Kappetein AP; Serruys PW; Bogers JJ
    Wien Klin Wochenschr; 2007; 119(11-12 Suppl 1):21-3. PubMed ID: 19618594
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological preconditioning of the heart during surgery.
    Landoni G; Figini F; Bignami E
    Eur J Cardiothorac Surg; 2010 Apr; 37(4):982-3; author reply 983. PubMed ID: 19853466
    [No Abstract]   [Full Text] [Related]  

  • 5. Ischaemic conditioning: are we there yet?
    Bulluck H; Hausenloy DJ
    Heart; 2015 Jul; 101(13):1067-77. PubMed ID: 25887783
    [No Abstract]   [Full Text] [Related]  

  • 6. Ischemic postconditioning's benefit on reperfusion ventricular arrhythmias is maintained in the senescent heart.
    Dow J; Bhandari A; Kloner RA
    J Cardiovasc Pharmacol Ther; 2008 Jun; 13(2):141-8. PubMed ID: 18495906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine pretreatment of human myocardium and ischemic preconditioning.
    Lee HT
    Circulation; 1998 Jun; 97(22):2279. PubMed ID: 9631881
    [No Abstract]   [Full Text] [Related]  

  • 8. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia-inducible factor 1 alpha in the heart.
    Czibik G; Wu Z; Berne GP; Tarkka M; Vaage J; Laurikka J; Järvinen O; Valen G
    Eur J Cardiothorac Surg; 2008 Nov; 34(5):976-84. PubMed ID: 18842422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moving preconditioning from bench to bedside.
    Kloner RA
    J Am Coll Cardiol; 2006 Jul; 48(1):215-6. PubMed ID: 16814670
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological preconditioning with hyperbaric oxygen: can this therapy attenuate myocardial ischemic reperfusion injury and induce myocardial protection via nitric oxide?
    Yogaratnam JZ; Laden G; Guvendik L; Cowen M; Cale A; Griffin S
    J Surg Res; 2008 Sep; 149(1):155-64. PubMed ID: 17996900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From coronary steal to myocardial, renal, and cerebral protection: more questions than answers in anaesthetic preconditioning?
    Kunst G
    Br J Anaesth; 2014 Jun; 112(6):958-60. PubMed ID: 24574506
    [No Abstract]   [Full Text] [Related]  

  • 12. Myocardial protection.
    Gordon RT
    Ann Thorac Surg; 1995 Mar; 59(3):791-2. PubMed ID: 7887747
    [No Abstract]   [Full Text] [Related]  

  • 13. An arm and a leg to protect the heart?
    Purcell H; Pepper J
    Lancet; 2007 Aug; 370(9587):542-3. PubMed ID: 17707732
    [No Abstract]   [Full Text] [Related]  

  • 14. The mechanism by which ischemic postconditioning reduces reperfusion arrhythmias in rats remains elusive.
    Dow J; Bhandari A; Kloner RA
    J Cardiovasc Pharmacol Ther; 2009 Jun; 14(2):99-103. PubMed ID: 19461101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of volatile and non volatile agents for cardioprotection during on-pump coronary surgery.
    De Hert S; Vlasselaers D; Barbé R; Ory JP; Dekegel D; Donnadonni R; Demeere JL; Mulier J; Wouters P
    Anaesthesia; 2009 Sep; 64(9):953-60. PubMed ID: 19686479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remote ischaemic preconditioning: the current best hope for improved myocardial protection in cardiac surgery?
    Rahman I; Bonser RS
    Heart; 2009 Oct; 95(19):1553-5. PubMed ID: 19628467
    [No Abstract]   [Full Text] [Related]  

  • 17. Rationale, design and baseline characteristics of the PRO-TECT II study: PROpofol CardioproTECTion for Type II diabetics: a randomized, controlled trial of high-dose propofol versus isoflurane preconditioning in patients undergoing on-pump coronary artery bypass graft surgery.
    Ansley DM; Raedschelders K; Chen DD; Choi PT
    Contemp Clin Trials; 2009 Jul; 30(4):380-5. PubMed ID: 19336262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat.
    Sivarajah A; McDonald MC; Thiemermann C
    Shock; 2006 Aug; 26(2):154-61. PubMed ID: 16878023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is protection by inhalation agents volatile? Controversies in cardioprotection.
    Zaugg M
    Br J Anaesth; 2007 Nov; 99(5):603-6. PubMed ID: 17933798
    [No Abstract]   [Full Text] [Related]  

  • 20. [Improvement and evaluation for the model of delayed myocardial ischemic preconditioning in rats in vitro].
    Wu YN; Liu YX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2005 May; 21(2):178-80, 199. PubMed ID: 21171337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.